| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/27/2006 | WO2006042947A1 Method for preparation of an autologous endometrial culture for an endometrium/embryo coculture |
| 04/27/2006 | WO2006042558A2 Group 2 mite polypeptide variants |
| 04/27/2006 | WO2006027545A3 Method |
| 04/27/2006 | WO2005118788A3 Novel artificial antigen presenting cells and uses therefor |
| 04/27/2006 | WO2005116070A9 Reporter system for detecting signal pathway activation in multiple cell types |
| 04/27/2006 | WO2005113747A3 Multicellular tissue and organ culture systems |
| 04/27/2006 | WO2005110491A3 Inducible dimerization of growth factor receptors for treating cancer |
| 04/27/2006 | WO2005100390A3 Bob-1 specific t cells and methods to use |
| 04/27/2006 | WO2005095457A3 Immunoglobulins |
| 04/27/2006 | WO2005094348A3 Anti-lfl2 antibodies for the diagnosis, prognosis and treatment of cancer |
| 04/27/2006 | WO2005094267A3 Methods for regulating differentiation of neural cells and uses thereof |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | WO2005085421A3 Treatment of spinal conditions |
| 04/27/2006 | WO2005077462A3 Cd70 inhibition for the treatment and prevention of inflammatory bowel disease |
| 04/27/2006 | WO2005049789A3 Synthetic mammalian retrotransposon gene |
| 04/27/2006 | WO2005034853A3 Uses of interferons with altered spatial structure |
| 04/27/2006 | WO2005033294A3 Methods for maintaining hepatocytes in culture and for differentiating embryonic stem cells along a hepatocyte lineage |
| 04/27/2006 | WO2005005601A3 Compositions and methods for treating and diagnosing cancer |
| 04/27/2006 | WO2004085624A3 Transaminases, deaminases and aminomutases and compositions and methods for enzymatic detoxification |
| 04/27/2006 | US20060090223 Vectors to express desired amino acid sequence in cells; regeneration; endosperm tissues; rice, corn, wheat, barley |
| 04/27/2006 | US20060090218 Method of controlling gene expression and gene silencing |
| 04/27/2006 | US20060090216 Promoter, promoter control elements, and combinations, and uses thereof |
| 04/27/2006 | US20060090215 Low allergen plant and animal genotypes |
| 04/27/2006 | US20060090212 Novel human genes and proteins encoded thereby |
| 04/27/2006 | US20060089523 Embryo modification and implantation |
| 04/27/2006 | US20060089490 Survival motor neuron (SMN) gene: a Gene for spinal muscular atrophy |
| 04/27/2006 | US20060089309 Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds |
| 04/27/2006 | US20060088938 Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants |
| 04/27/2006 | US20060088935 Method of ex vitro sowing, germination, growth and conversion of plant somatic embryos or germinants, and nutrient medium used therefor |
| 04/27/2006 | US20060088934 Methods for regulating the growth and/or survival of tumor cells and stem cells by modulating the expression or function of the transcription factor ATF5 |
| 04/27/2006 | US20060088933 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay |
| 04/27/2006 | US20060088917 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088916 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088912 Compositions and methods of purifying myelin-associated glycoprotein (MAG) |
| 04/27/2006 | US20060088907 Novel 13237, 18480, 2245, 16228, 7677, 26320, 46619, 33166, 16836, 46867, 21617, 55562, 39228, 62088, 46745, 23155, 21657, 42755, 32229, 22325, 46863 and 32252 molecules and uses therefor |
| 04/27/2006 | US20060088898 Methods for the production of cells and mammals with desired genetic modifications |
| 04/27/2006 | US20060088890 Identification and isolation of somatic stem cells and uses thereof |
| 04/27/2006 | US20060088879 DNA polymerases having improved labeled nucleotide incorporation properties |
| 04/27/2006 | US20060088874 Methods and kits for detecting mutations |
| 04/27/2006 | US20060088854 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/27/2006 | US20060088841 Reversible, parallel and multitask cloning method and kit |
| 04/27/2006 | US20060088824 Used in assays to identify PAP-1/WIP-1 interaction inhibitors; West Nile virus (WNV) |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088527 Lung tumor polynucleotides, polypeptides, fusion proteins, antigen presenting cells, T-cells and vaccines containing the polypeptide and an immunostimulant; genetic vaccines; improved early detection |
| 04/27/2006 | US20060088511 Cancer therapy sensitizer |
| 04/27/2006 | US20060088509 Isolated clk-1 -/- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders |
| 04/27/2006 | US20060088508 Method for obtaining characterized muscle-derived cell populations and uses |
| 04/27/2006 | US20060088506 Process for producing cartilage cells for transplantation |
| 04/27/2006 | US20060088505 Hair follicle mesenchymal stem cells and use thereof |
| 04/27/2006 | US20060087736 Amyloid peptide inactivating enzyme to treat alzheimer's disease |
| 04/27/2006 | CA2827654A1 Method for generating an animal homozygous for a genetic modification |
| 04/27/2006 | CA2626363A1 Compositions and methods for prolonging survival of platelets |
| 04/27/2006 | CA2584738A1 Generation and differentiation of adult stem cell lines |
| 04/27/2006 | CA2584661A1 Increased wax production in plants |
| 04/27/2006 | CA2584116A1 Neurotransmitter sensors and methods of using the same |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2583750A1 Methods for generating a rodent having a genetic modification |
| 04/27/2006 | CA2583690A1 Microrna constructs for the suppression of the expression of targeted genes or the down regulation of targeted genes and methods therefore |
| 04/27/2006 | CA2583473A1 Neuronal progenitors from feeder-free human embryonic stem cell culture |
| 04/27/2006 | CA2583186A1 Method for preparation of an autologous endometrial culture for an endometrium/embryo coculture |
| 04/27/2006 | CA2581278A1 Methods and materials for the inhibition of transplant rejection |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1650307A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/26/2006 | EP1650303A2 Method for generating a substracted cDNA library and uses of the generated library |
| 04/26/2006 | EP1650295A1 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process |
| 04/26/2006 | EP1650294A1 Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCS, use thereof for cloning and chimerization |
| 04/26/2006 | EP1650293A1 Magnetic cell and method of using the same |
| 04/26/2006 | EP1650292A1 Method of storing and/or transporting in vitro cell cultures |
| 04/26/2006 | EP1650225A1 Hetero type pentamer recombinant vaccine |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650220A2 Anti-VEGF antibodies |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1649879A2 Decellularized tissue |
| 04/26/2006 | EP1649875A1 Method of constructing artificial joint |
| 04/26/2006 | EP1649746A1 MSH5 ablated mice and uses therefor |
| 04/26/2006 | EP1649021A1 Plant cell cycle genes and methods of use |
| 04/26/2006 | EP1649020A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 04/26/2006 | EP1649013A2 Cartilage and bone repair and regeneration using postpartum-derived cells |
| 04/26/2006 | EP1649012A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 04/26/2006 | EP1649011A2 Novel keratinocyte culturing method and the use thereof |
| 04/26/2006 | EP1649010A2 Novel nucleic acids from sesame plants |
| 04/26/2006 | EP1649009A2 Extended primary retinal cell culture and stress models, and methods of use |
| 04/26/2006 | EP1649008A2 Aligned scaffolds for improved myocardial regeneration |
| 04/26/2006 | EP1649007A2 Methods for ex-vivo expanding stem/progenitor cells |
| 04/26/2006 | EP1649003A2 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 04/26/2006 | EP1649002A2 Rna processing protein complexes and uses thereof |
| 04/26/2006 | EP1649000A2 Seeding pancreatic cells on porous matrices |
| 04/26/2006 | EP1648999A2 Systems and methods for separating and concentrating regenerative cells from tissue |
| 04/26/2006 | EP1648994A2 Bio-artificial liver system |
| 04/26/2006 | EP1648948A1 Thermosensitive polymers for therapeutic use and methods of preparation |
| 04/26/2006 | EP1648935A2 Antagonists and agonists of ldcam and methods of use |
| 04/26/2006 | EP1648533A1 Decellularized extracellular matrix of conditioned body tissues and uses thereof |
| 04/26/2006 | EP1648521A1 Compositions and methods for treating cardiac dysfunction |
| 04/26/2006 | EP1648520A1 Compounds and methods for downregulating the effects of tgf-beta |
| 04/26/2006 | EP1648512A2 Anti-cd19 antibodies |
| 04/26/2006 | EP1648508A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using alloreactive natural killer cells |
| 04/26/2006 | EP1648507A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |